Form 8-K - Current report:
SEC Accession No. 0001104659-24-116329
Filing Date
2024-11-12
Accepted
2024-11-12 07:08:47
Documents
17
Period of Report
2024-11-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2427095d1_8k.htm   iXBRL 8-K 38504
2 EXHIBIT 10.1 tm2427095d1_ex10-1.htm EX-10.1 32152
3 EXHIBIT 99.1 tm2427095d1_ex99-1.htm EX-99.1 15976
7 GRAPHIC tm2427095d1_ex10-1img001.jpg GRAPHIC 12241
8 GRAPHIC tm2427095d1_ex99-1img001.jpg GRAPHIC 20003
  Complete submission text file 0001104659-24-116329.txt   326061

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA egrx-20241108.xsd EX-101.SCH 3012
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE egrx-20241108_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE egrx-20241108_pre.xml EX-101.PRE 22357
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2427095d1_8k_htm.xml XML 3708
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 241443230
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)